Apyx Medical (APYX) vs Neuronetics (STIM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Apyx Medical (APYX) has outperformed Neuronetics (STIM) over the past year, losing 10.2% versus a loss of 25.4%. Over five years, STIM leads with a -55.3% price change compared with -80.6% for APYX. Neuronetics is the larger company by market cap ($165.3 million vs $107.4 million), about 1.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | APYX | STIM |
|---|---|---|
| Share price | $2.55 | $2.17 |
| Market cap | $107.42M | $165.35M |
| 1-day change | +0.20% | -1.81% |
| YTD return | -27.14% | +57.25% |
| 1-year return | -10.21% | -25.43% |
| 5-year return | -80.61% | -55.35% |
| EPS (TTM) | $-0.20 | $-0.42 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.08 | $3.44 |
| 52-week low | $2.32 | $0.80 |
| Distance from 52-week high | -49.80% | -36.92% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +164.98% |
| Average volume | 126.16K | 2.10M |
| Shares outstanding | 42.12M | 76.20M |
| Employees | — | 658 |
| Sector | Health Care | Healthcare |
| Industry | Medical/Dental Instruments | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- APYX has outperformed STIM by 15.2 percentage points over the past year.
- The two companies sit in different sectors: Apyx Medical in Health Care and Neuronetics in Healthcare.
About Neuronetics
STIM stock →Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally.
Healthcare · Medical Devices · 658 employees
APYX vs STIM FAQ
Which is bigger, Apyx Medical or Neuronetics?
Neuronetics (STIM) is larger, with a market capitalization of $165.35M compared with $107.42M for Apyx Medical (APYX).
Which stock has performed better over the past year, APYX or STIM?
APYX returned -10.21% over the past 12 months, compared with -25.43% for STIM (price return, excluding dividends). Past performance does not predict future results.
Are Apyx Medical and Neuronetics in the same industry?
No. Apyx Medical is in the Health Care sector, while Neuronetics is in Healthcare.